Literature DB >> 29941666

Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery.

Yoshihiro Morishima1, Ranjit K Mehta1, Miyako Yoshimura1, Miranda Lau1, Daniel R Southworth1, Theodore S Lawrence1, William B Pratt1, Mukesh K Nyati1, Yoichi Osawa2.   

Abstract

Several hundred proteins cycle into heterocomplexes with a dimer of the chaperone heat shock protein 90 (Hsp90), regulating their activity and turnover. There are two isoforms of Hsp90, Hsp90α and Hsp90β, and their relative chaperone activities and composition in these client protein•Hsp90 heterocomplexes has not been determined. Here, we examined the activity of human Hsp90α and Hsp90β in a purified five-protein chaperone machinery that assembles glucocorticoid receptor (GR)•Hsp90 heterocomplexes to generate high-affinity steroid-binding activity. We found that human Hsp90α and Hsp90β have equivalent chaperone activities, and when mixed together in this assay, they formed only GRHsp90αα and GRHsp90ββ homodimers and no GRHsp90αβ heterodimers. In contrast, GRHsp90 heterocomplexes formed in human embryonic kidney (HEK) cells also contain GRHsp90αβ heterodimers. The formation of GRHsp90αβ heterodimers in HEK cells probably reflects the longer time permitted for exchange to form Hsp90αβ heterodimers in the cell versus in the cell-free assembly conditions. This purified GR-activating chaperone machinery can be used to determine how modifications of Hsp90 affect its chaperone activity. To that effect, we have tested whether the unique phosphorylation of Hsp90α at threonines 5 and 7 that occurs during DNA damage repair affects its chaperone activity. We showed that the phosphomimetic mutant Hsp90α T5/7D has the same intrinsic chaperone activity as wild-type human Hsp90α in activation of GR steroid-binding activity by the five-protein machinery, supporting the conclusion that T5/7 phosphorylation does not affect Hsp90α chaperone activity.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29941666      PMCID: PMC6064783          DOI: 10.1124/mol.118.112516

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

1.  Coordinated ATP hydrolysis by the Hsp90 dimer.

Authors:  K Richter; P Muschler; O Hainzl; J Buchner
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

2.  Regulation of glucocorticoid receptor ligand-binding activity by the hsp90/hsp70-based chaperone machinery.

Authors:  Kimon C Kanelakis; William B Pratt
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

3.  Heat shock protein 90α (Hsp90α) is phosphorylated in response to DNA damage and accumulates in repair foci.

Authors:  Maria Quanz; Aurélie Herbette; Mano Sayarath; Leanne de Koning; Thierry Dubois; Jian-Sheng Sun; Marie Dutreix
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 4.  Targeting the dynamic HSP90 complex in cancer.

Authors:  Jane Trepel; Mehdi Mollapour; Giuseppe Giaccone; Len Neckers
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

5.  The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues.

Authors:  S P Lees-Miller; C W Anderson
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

6.  Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket.

Authors:  Y Morishima; P J Murphy; D P Li; E R Sanchez; W B Pratt
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.

Authors:  J Zou; Y Guo; T Guettouche; D F Smith; R Voellmy
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

8.  Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.

Authors:  Stefan H Millson; Andrew W Truman; Attila Rácz; Bin Hu; Barry Panaretou; James Nuttall; Mehdi Mollapour; Csaba Söti; Peter W Piper
Journal:  FEBS J       Date:  2007-08-06       Impact factor: 5.542

9.  ATM is the primary kinase responsible for phosphorylation of Hsp90α after ionizing radiation.

Authors:  Ameer L Elaimy; Aarif Ahsan; Katherine Marsh; William B Pratt; Dipankar Ray; Theodore S Lawrence; Mukesh K Nyati
Journal:  Oncotarget       Date:  2016-12-13

Review 10.  Hsp90: A New Player in DNA Repair?

Authors:  Rosa Pennisi; Paolo Ascenzi; Alessandra di Masi
Journal:  Biomolecules       Date:  2015-10-16
View more
  6 in total

Review 1.  Immunologic and Non-Immunologic Mechanisms Leading to Airway Remodeling in Asthma.

Authors:  Lei Fang; Qinzhu Sun; Michael Roth
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923

Review 2.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

3.  Xiaoyaosan (Tiaogan-Liqi therapy) protects peritoneal macrophages from corticosterone-induced stress by regulating the interaction between glucocorticoid receptor and ABCA1.

Authors:  Mingtai Chen; Ruolan Huang; Wenjun Fu; Lijun Ou; Ling Men; Zhong Zhang; Shudong Yang; Qiang Liu; Jienan Luan
Journal:  Ann Transl Med       Date:  2020-11

Review 4.  Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem.

Authors:  Lee-Maine L Spies; Nicolette J D Verhoog; Ann Louw
Journal:  Cells       Date:  2021-09-24       Impact factor: 6.600

Review 5.  Chemical Screening of Nuclear Receptor Modulators.

Authors:  Mari Ishigami-Yuasa; Hiroyuki Kagechika
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 6.  The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases.

Authors:  Richard J Roberts; Logan Hallee; Chi Keung Lam
Journal:  J Pers Med       Date:  2021-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.